Plain-English translation of NCT07477704 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing , a medication designed to lower LDL cholesterol (the 'bad' cholesterol), given as a weekly injection instead of the current schedule. Researchers want to find the best weekly dose that is both safe and effective for adults with high cholesterol. The medication is already approved by the FDA, but this study is exploring whether giving it weekly works well.
Currently, this medication requires injections every two weeks or monthly, which can be inconvenient for patients. This study explores whether a weekly dosing schedule could work just as well or better, making treatment easier to manage.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive one of four different doses of the medication given as a weekly injection. Throughout the study, you would have regular visits where researchers check your cholesterol levels, monitor for any side effects, and measure how much medication is in your blood. The study involves about 420 participants total, and your specific role would depend on which dose group you're assigned to.
AI-generated summary from trial data · Jul 17, 2026 · Not medical advice
United States